We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ELC Group Announces Appointment of Dr. Siddharth Chachad
News

ELC Group Announces Appointment of Dr. Siddharth Chachad

ELC Group Announces Appointment of Dr. Siddharth Chachad
News

ELC Group Announces Appointment of Dr. Siddharth Chachad

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ELC Group Announces Appointment of Dr. Siddharth Chachad"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ELC Group has announced the appointment of internationally acclaimed clinical pharmacologist Dr. Siddharth Chachad as Head of Global Clinical Development and Medical Affairs.

A member of the UK Faculty of Pharmaceutical Medicine, Dr. Chachad is an expert in the design and execution of pre-clinical and clinical development programme for drug products across dosage forms and therapeutic categories. Dr. Chachad has gained considerable career experience in the delivery medical services, medico-regulatory affairs and clinical development, and has worked across global clinical development strategy and operations of generics, new drugs and biosimilars. Dr. Siddharth’s extensive expertise covers all phases of clinical studies, including pre-clinical, pharmacodynamic studies, bioequivalence, PK in patients and full-blown clinical efficacy and safety studies.

“The appointment of Dr. Siddharth Chachad comes at a pivotal time for ELC Group,” said Marco Rubenstein, CEO of ELC Group. “Having been instrumental in the development of successful product registration strategies, I have no doubt that Dr. Siddarth will prove an exceptional leader of our Global Clinical Development and Medical Affairs team.”

Dr. Chachad added: “I am excited to be joining ELC Group and bringing my experience of Clinical Development and Medical Affairs to what is already a world-class team in this area.”

A renowned speaker at numerous clinical research and pharmacovigilance conferences, Dr. Chachad has authored over 25 publications.

Advertisement